SFX by Ex Libris Inc.

Title:	Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion
Source:	Science [0036-8075] Campuzano, V yr:1996

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Durr, A. "Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia." New England Journal of Medicine, The 335.16 (1996): 1169-1175.
description	2.	Campuzano, V.. "Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes." Human Molecular Genetics 6.11 (1997): 1771-1780.
description	3.	Montermini, L. "Friedreich ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion." Neurology 47.1 (1996): 294-294.
description	4.	Foury, F. "Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria." FEBS letters 411.2-3 (1997): 373-377.
description	5.	Roetig, A. "Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia." Nature genetics 17.2 (1997): 215-7.
description	6.	Forrest, M B B. "Friedreich ataxia: an overview." Journal of medical genetics 37.1 (1999): 1-8.
description	7.	Madhani, H D D. "Genetic abnormalities in Friedreich's ataxia." The New England journal of medicine 336.14: 1022-1022.
description	8.	Puccio, H. "Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits." Nature genetics 27.2 (2001): 181-6.
description	9.	Babcock, M. "Regulation of mitochondrial iron accumulation by Yfh 1p, a putative homolog of frataxin." Science 276.5319 (1997): 1709-1712.
description	10.	Timann, P. "International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology." Journal of the Neurological Sciences 145.2 (1997): 205-11.
description	11.	Samii, A. "Parkinson's disease." The lancet 365.9459: 1783-1793.
description	12.	Beal, M. "Mitochondrial dysfunction in neurodegenerative diseases." Biochimica et biophysica acta. Bioenergetics 1366.1-2 (1998): 211-223.
description	13.	Abou-Sleymane, G. "Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program." Human molecular genetics 15.5 (2006): 691-703.
description	14.	Wells, R.D. D. "Advances in mechanisms of genetic instability related to hereditary neurological diseases." Nucleic Acids Research 33.12 (2005): 3785-3798.
description	15.	Monrós, E. "Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat." American journal of human genetics 61.1 (1997): 101-10.
description	16.	Yoo, C. "The yeast la protein is required for the 3' endonucleolytic cleavage that matures tRNA precursors." Cell 89.3 (1997): 393-402.
description	17.	Pandolfo, M. "The molecular basis of Friedreich ataxia." Advances in experimental medicine and biology 516.Triple Repeat Diseases of the Nervous System (2002): 99-118.
description	18.	Cossee, M. "Friedreich's ataxia: Point mutations and clinical presentation of compound heterozygotes." Annals of neurology 45.2 (1999): 200-206.
description	19.	Johnson, Deborah C C. "Structure, function, and formation of biological iron-sulfur clusters." Annual review of biochemistry 74.1 (2005): 247-81.
description	20.	Nelson, S. "Parkinson's disease." Nursing standard 22.19 (2008): 59-60.